Stay updated with breaking news from Lon Azn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Barclays reiterated their overweight rating on shares of AstraZeneca (LON:AZN – Free Report) in a research note released on Monday morning, MarketBeat.com reports. Barclays currently has a £125 ($158.21) target price on the biopharmaceutical company’s stock. Several other equities analysts also recently issued reports on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a sell rating on […]
AstraZeneca PLC (LON:AZN – Get Free Report) has been given an average rating of “Moderate Buy” by the ten ratings firms that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to […]
AstraZeneca PLC (LON:AZN – Get Free Report)’s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of £106.03 ($134.79) and traded as high as £106.14 ($134.94). AstraZeneca shares last traded at £105.68 ($134.35), with a volume of 2,345,376 shares trading hands. Wall Street Analyst […]
Shares of AstraZeneca PLC (LON:AZN – Get Free Report) have received an average rating of “Moderate Buy” from the nine ratings firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1-year price […]
Shares of AstraZeneca PLC (LON:AZN – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine ratings firms that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average twelve-month price […]